FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular, to experimental cardiopharmacology, and can be used for modelling and correction of endothelial dysfunction. For this purpose in experiment endothelial dysfunction is modelled by creation of hypoestrogenic condition by bilateral ovariectomy in laboratory animal and during 6 weeks by addition into food of fructose, specific weight of which constitutes 60% of total ration, as well as by daily single irritation by electric current with 10 ms, voltage 30 V, intensity 0.66 mA, passed through electrodes, applied on animal's tail moistened with physiological solution. Degree of endothelial dysfunction development is evaluated by ratio of endothelium-independent and endothelium-dependent vasodilation, and formation of metabolic disorders by change of glycemia level by 120 minute in oral test on tolerance to glucose. Claimed model can be applied for estimation of pharmacological correction of endothelial dysfunction in reproduction of metabolic disorders.
EFFECT: method makes it possible to estimate dynamics of formation of endothelial dysfunction in modelling of metabolic disorders with application of fructose-containing diet and electric current.
1 ex, 3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH SOLVENT MIXTURE OF HOMEOPATHIC DILUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE C12, C30, C200 | 2006 |
|
RU2306953C1 |
| METHOD OF CORRECTION OF HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION WITH FUROSTANOL GLYCOSIDES OF CELL CULTURE OF Dioscorea deltoidea | 2006 |
|
RU2329807C2 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2421822C2 |
| METHOD FOR HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION CORRECTION WITH MIXED SOLUTIONS OF HOMOEOPATHIC DILUTIONS OF POLYCLONAL RABBIT C12, C30, C200 ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE | 2010 |
|
RU2438191C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF ENALAPRIL AND RESVERATROL IN L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 |
|
RU2301670C1 |
| METHOD OF LAMOTRIGINE CORRECTION OF ENDOTHELIAL DYSFUNCTION ASSOCIATED WITH L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2008 |
|
RU2367421C1 |
| METHOD OF PICAMILONUM-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364393C1 |
| METHOD OF ACETYLSALICYLIC ACID BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364392C1 |
| METHOD OF CLOPIDOGREL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364394C1 |
| METHOD OF TADALAFIL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364395C1 |
